PLA2R1 and lipoprotein glomerulopathy: We used time-resolved fluoroimmunoassay (TRFIA), a new technique to measure PLA2R-Ab titers, and analyzed the correlation between PLA2R-Ab and the clinical features of IMN among a cohort of patients with glomerulopathy.